<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Accentia Biopharmaceuticals Inc. | Company News & Executive Profiles - ABPI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Accentia Biopharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="6" found="6" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals to Present at Rodman & Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_24/ai_n30934576]]></link>
		<description><![CDATA[TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008 at 10:20 a.m. EDT at the New York Palace Hotel in New York City. The Company's presentation will focus on its BiovaxID[R] personalized anti-cancer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 24 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[compliance]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ABPI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals Reports Fiscal Second Quarter Financial Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_16/ai_n25431221]]></link>
		<description><![CDATA[Company to Present at Jefferies Healthcare Conference  TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that the Company has filed its Quarterly Report (Form 10-Q) with the SEC, reporting the results of its operations, including consolidated results with its majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), for its second...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 16 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ABPI,BVTI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[NIAID Supports Research Into Etiology of Fungal-Induced Inflammation in Chronic Sinusitis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_1/ai_n27259689]]></link>
		<description><![CDATA[Grant Supports Identification of Fungal Antigens Responsible for Chronic Sinusitis Which May Also Play a Role in Asthma  Accentia Biopharmaceuticals is the Exclusive Licensee to an Intranasal Antifungal for Treatment of Chronic Sinusitis  TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI; Accentia) reports that the Mayo Medical and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/inflammation.html"><![CDATA[inflammation]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/professor.html"><![CDATA[professor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">ABPI,BVTI</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_May_14/ai_n27237560]]></link>
		<description><![CDATA[European Patent Office Communicates Grant of Key Patent for European Union  Company Extends Control of the Exclusive Worldwide Rights to All Prescription Antifungals  TAMPA, Fla. -- Accentia Biopharmaceuticals Inc. (NASDAQ: ABPI; "Accentia") has made a milestone payment to the Mayo Foundation for Medical Education and Research ("Mayo") for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[payment]]></category>
		<category domain="http://resources.bnet.com/topic/pivotal+corp..html"><![CDATA[Pivotal Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">ABPI,BVTI</category>
	</item>
	<item>
		<title><![CDATA[PharmaNet Development Group Announces Strategic Alliance with Analytica International]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_March_19/ai_n27184212]]></link>
		<description><![CDATA[PRINCETON, N.J. & NEW YORK -- PharmaNet Development Group, Inc. (NASDAQ: PDGI) and Analytica International, Inc., a wholly-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI), today announced that they have entered into a strategic alliance that will allow the companies to provide a broader range of clinical development and commercialization...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ABPI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[ACCENTIA TO LICENSE ALL MAYO ANTIFUNGALS FOR CHRONIC SINUSITIS.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6494/is_200609/ai_n25837013]]></link>
		<description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), Tampa, Fla., has  signed an amendment to its exclusive option agreement with the Mayo  Foundation for Medical Research and Education Mayo Clinic to license  any and all intranasal antifungals for chronic sinusitis. The amendment  extends the exclusive option agreement an additional year...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Sep 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="tickers">ABPI</category>
	</item>
</channel>
</rss>
